[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Mon, Aug 3rd, 2026

Cannabis Stocks Profiles

View company profiles of publicly traded cannabis, marijuana, and 420 friendly Stocks.
Mon, Aug 3rd, 2026

Cannabis/marijuana stocks represent new investment opportunities as public companies provide products and services for medical and recreational use. Worldwide spending on legal cannabis reached $21.3 billion in 2020 and some analysts expect that that number could surpass $50 billion if nationwide legalization were to occur. Given this potential opportunity, investors are now speculating which marijuana-related stocks could become the dominant players in the future. Barchart’s cannabis stocks list is a great starting point that will allow you to find investment opportunities and compare stocks involved in the growing cannabis industry.

Tilray Brands Inc (TLRY.TO)

Full Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

52-Week Low
52-Week High
5.19
32.30

Overview:

Market Capitalization, $K 869,344
Shares Outstanding, K 136,204
Last Quarter Sales 281,714 K
Last Quarter Net Income -49,572 K
% Insider Shareholders N/A
% Institutional Shareholders 4.05%

Cardiol Therapeutics Inc (CRDL.TO)

Full Profile

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

52-Week Low
52-Week High
1.23
2.33

Overview:

Market Capitalization, $K 202,879
Shares Outstanding, K 115,272
Last Quarter Sales 0 K
Last Quarter Net Income -10,819 K
% Insider Shareholders N/A
% Institutional Shareholders 0.05%

Aurora Cannabis Inc (ACB.TO)

Full Profile

Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.

52-Week Low
52-Week High
3.59
9.33

Overview:

Market Capitalization, $K 240,336
Shares Outstanding, K 61,942
Last Quarter Sales 38,013 K
Last Quarter Net Income -71,101 K
% Insider Shareholders N/A
% Institutional Shareholders 4.21%

Canopy Growth Corporation (WEED.TO)

Full Profile

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

52-Week Low
52-Week High
1.18
3.28

Overview:

Market Capitalization, $K 544,580
Shares Outstanding, K 422,155
Last Quarter Sales 71,245 K
Last Quarter Net Income -157,115 K
% Insider Shareholders N/A
% Institutional Shareholders 4.32%

Cronos Group Inc (CRON.TO)

Full Profile

Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.

52-Week Low
52-Week High
2.67
4.66

Overview:

Market Capitalization, $K 1,475,965
Shares Outstanding, K 373,662
Last Quarter Sales 45,210 K
Last Quarter Net Income 13,752 K
% Insider Shareholders N/A
% Institutional Shareholders 4.36%

Organigram Global Inc (OGI.TO)

Full Profile

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

52-Week Low
52-Week High
1.20
3.09

Overview:

Market Capitalization, $K 184,415
Shares Outstanding, K 140,775
Last Quarter Sales 59,794 K
Last Quarter Net Income -921 K
% Insider Shareholders N/A
% Institutional Shareholders 3.91%

High Tide Inc (HITI.VN)

Full Profile

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.

52-Week Low
52-Week High
2.860
5.590

Overview:

Market Capitalization, $K 260,974
Shares Outstanding, K 87,870
Last Quarter Sales 179,296 K
Last Quarter Net Income -197 K
% Insider Shareholders N/A
% Institutional Shareholders 4.74%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.